Psychiatry Research
Volume 170, Issue 2 , Pages 172-176 , 30 December 2009

Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: Effect modification or regression to the mean?

  • David B. Allison

      Affiliations

    • Clinical Nutrition Research Center and Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
    • Corresponding Author InformationCorresponding author. University of Alabama at Birmingham, 1665 University Blvd. RPHB 414, Birmingham, AL 35294, USA. Tel.: +1 205 975 9169; fax: +1 205 975 2540.
    • ,
  • Antony D. Loebel

      Affiliations

    • Pfizer, Inc., New York, NY, USA
    • ,
  • Ilise Lombardo

      Affiliations

    • Pfizer, Inc., New York, NY, USA
    • ,
  • Steven J. Romano

      Affiliations

    • Pfizer, Inc., New York, NY, USA
    • ,
  • Cynthia O. Siu

      Affiliations

    • Data Power (DP), Inc., Ringoes, NJ, USA

Received 15 April 2008 ,Revised 18 September 2008 ,Accepted 9 October 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0165-1781(08)00350-8

doi: 10.1016/j.psychres.2008.10.007

Psychiatry Research
Volume 170, Issue 2 , Pages 172-176 , 30 December 2009

Article Tools

* Image Usage & Resolution